Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

29%

5 trials in Phase 3/4

Results Transparency

33%

5 of 15 completed with results

Key Signals

5 with results94% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (1)
P 1 (6)
P 2 (1)
P 3 (2)
P 4 (3)

Trial Status

Completed15
Unknown1
Terminated1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06761131Completed

Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

NCT04620590Phase 4Completed

Dapagliflozin Treatment in Type 2 Diabetes

NCT02467478Phase 4Completed

Linagliptin's Effect on CD34+ Stem Cells

NCT01716455Phase 1CompletedPrimary

Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function

NCT03776539Phase 1CompletedPrimary

A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

NCT01035320Phase 4Completed

Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment

NCT02431481Phase 1Completed

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

NCT01507350CompletedPrimary

Effects of Obesity Surgery on Renal Function

NCT04252430Phase 1Terminated

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

NCT04179630Phase 1CompletedPrimary

Study of Aldafermin (NGM282) in Participants With Impaired Renal Function

NCT02965040Phase 1Completed

A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function

NCT00981045Phase 3Completed

Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function

NCT00779922Phase 2Completed

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

NCT00604357Phase 3Completed

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

NCT02087566Not ApplicableCompleted

Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

NCT01760031UnknownPrimary

Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy

NCT00784381CompletedPrimary

Computer Prescribing System and Impaired Renal Function

Showing all 17 trials

Research Network

Activity Timeline